%25255BAngiogenesis inhibitors for the systemic treatment of…
%25255BAngiogenesis inhibitors for the systemic treatment of metastatic renal cell carcinoma%25253A sunitinib%25252C sorafenib%25252C bevacizumab and temsirolimus%25255D
Article, Chapter
Authors:
P.H.M. de Mulder
Publication:
Volume:152,
Page(s):371
Published:
2008
We were unable to find direct full text links for this item.